marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Brainstorm Cell Therapeutics Cash Flow 2011-2024 | BCLI
Annual Cash Flow Brainstorm Cell Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-20.5 M | -19.3 M | -26.3 M | -35.2 M | -11.2 M | -12.4 M | -2.36 M | -5.86 M | - | -4.49 M | -4.05 M | -2.94 M | -2.22 M |
Depreciation & Amortization |
265 K | 285 K | 260 K | 219 K | 164 K | 110 K | 85 K | 77 K | 87 K | 106 K | 97 K | 157 K | 153 K |
Accounts Payables |
4.95 M | 6.22 M | 3.7 M | 5.42 M | 14.7 M | 4.55 M | 1.42 M | 345 K | 1.17 M | 1.54 M | 228 K | 358 K | 244 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | 312 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Brainstorm Cell Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-1.68 M | -3.06 M | - | -6.41 M | -6.78 M | -3.99 M | - | -4.85 M | -6.13 M | -3.69 M | - | -6.46 M | -5.33 M | -8.97 M | - | -6.92 M | -5.66 M | -15 M | - | -3.63 M | -3.51 M | -835 K | - | -6.59 M | 55 K | -2.13 M | - | 3.84 M | -1.63 M | -1.64 M | - | - | - | - | - | - | - | -1.94 M | - | -1.12 M | -970 K | -391 K | - | -713 K | -1.06 M | -670 K | - | -1.07 M | -419 K | -746 K | - | -897 K | -855 K | -55 K |
Depreciation & Amortization |
64 K | 64 K | - | 65 K | 67 K | 67 K | - | 70 K | 71 K | 74 K | - | 67 K | 62 K | 61 K | - | 56 K | 50 K | 49 K | - | 37 K | 33 K | 44 K | - | 33 K | 31 K | 25 K | - | 23 K | 18 K | 16 K | - | 17 K | 22 K | 16 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
5.34 M | 4.69 M | 4.95 M | 3.93 M | 5.19 M | 7.8 M | 6.22 M | 6.4 M | 5.29 M | 4.57 M | 3.7 M | 2.74 M | 3 M | 2.55 M | 5.42 M | 5.42 M | 5.42 M | 5.42 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 4.55 M | 4.55 M | 4.55 M | 4.55 M | 1.42 M | 1.42 M | 1.42 M | 1.42 M | 345 K | 345 K | 345 K | 345 K | 1.17 M | 1.17 M | 1.17 M | 1.17 M | 1.54 M | 1.54 M | 1.54 M | 1.54 M | 228 K | 228 K | 228 K | 228 K | 358 K | 358 K | 358 K | 358 K | 244 K | 244 K | 244 K | 244 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 449 K | 421 K | 482 K | 312 K | 369 K | 312 K | 312 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency